Chest Symptoms and Long-Term Risk of Incident Cardiovascular Disease
- PMID: 39084313
- PMCID: PMC11585413
- DOI: 10.1016/j.amjmed.2024.07.009
Chest Symptoms and Long-Term Risk of Incident Cardiovascular Disease
Abstract
Background: We sought to evaluate the associations of chest pain and dyspnea with the long-term risk of cardiovascular disease including coronary disease, heart failure, atrial fibrillation, and stroke.
Methods: In 13,200 participants without cardiovascular disease in the Atherosclerosis Risk in Communities study (1987-1989), chest pain was categorized into definite angina, possible angina, non-anginal chest pain, and no chest pain using the Rose questionnaire. Dyspnea was categorized into grades 3-4, 2, 1, and 0 by the modified Medical Research Council scale. The associations of chest pain and dyspnea with incident myocardial infarction, heart failure, atrial fibrillation, and stroke over a median follow-up of ∼27 years were quantified with multivariable Cox models.
Results: Definite angina and possible angina were associated with myocardial infarction (adjusted hazard ratios [HR] 1.80 [95%CI 1.45-2.13] and 1.65 [1.27-2.15]). Although lesser magnitude than myocardial infarction, both definite and possible angina were associated with heart failure. For atrial fibrillation, possible angina showed higher HR than definite angina. Dyspnea showed similar HRs for myocardial infarction and heart failure in grades 3-4 (2.00 [1.61-2.49] and 1.94 [1.62-2.32]). Stroke was least associated with chest symptoms. Chest pain and dyspnea significantly improved the discrimination of cardiovascular disease except stroke, beyond traditional risk factors.
Conclusions: In individuals without cardiovascular disease, chest pain and dyspnea were independently associated with incident cardiovascular disease for about 3 decades, suggesting the need for evaluating chest pain from a broader perspective of cardiovascular disease beyond coronary disease and the importance of dyspnea for cardiovascular risk assessment including myocardial infarction.
Keywords: Atrial fibrillation; Chest pain; Dyspnea; Heart failure; Myocardial infarction.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest disclosure:
Dr Rosamond received grants from National Heart, Lung, and Blood Institute.
Dr Shah received consulting fees from Phillips Ultrasound and Jansen.
Dr Blaha received grants from Amgen, American Heart Association, Bayer, Food and Drug Administration, National Institute of Health, and Novo Nordisk; consulting fees from Agepha, Astra Zeneca, Bayer, Boehringer Ingelheim, Eli Lily, Merck, Novartis, and Novo Nordisk; honoraria for lectures from Novo Nordisk; payment for expert testimony from Novo Nordisk and US FTC.
Dr Mathews received grants from National Heart, Lung, and Blood Institute.
Dr Matsushita received grants from Resolve to Save Lives; consulting fees from AMGA, Kowa Company, and Rhythm X AI; honoraria for lectures fee from Fukuda Denshi.
The other authors have nothing to declare.
Conflict of interest disclosure: None.
References
-
- Rui PK K. National Hospital Ambulatory Medical Care Survey: 2017 emergency department summary tables. Vol 20232021.
-
- Johnson K, Ghassemzadeh S. Chest Pain. StatPearls [Internet]. Vol 2023. Treasure Island (FL): StatPearls Publishing; 2023. - PubMed
-
- Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e368–e454. doi:10.1161/cir.0000000000001029. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical